Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
Loading ADAP News...
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.76% | 172.50 | 1.1% | $711.75m | |
| GILD | Gilead Sciences, Inc. | 0.09% | 70.54 | 0.9% | $695.99m | |
| CELG | Celgene Corporation | 0.47% | 134.31 | 1.1% | $649.60m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.75% | 517.33 | 2.7% | $572.31m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.13% | 126.07 | 1.9% | $521.18m | |
| BIIB | Biogen Inc. | -0.09% | 280.32 | 1.2% | $500.23m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.50% | 133.50 | 1.9% | $279.31m | |
| INCY | Incyte Corporation | 0.48% | 136.28 | 2.6% | $278.87m | |
| CLVS | Clovis Oncology, Inc. | -1.84% | 95.00 | 18.0% | $249.90m | |
| TSRO | TESARO, Inc. | -2.16% | 146.53 | 14.7% | $249.01m | |
| ILMN | Illumina, Inc. | 1.25% | 185.28 | 3.5% | $164.61m | |
| BLUE | Bluebird Bio, Inc. | -5.49% | 112.00 | 19.3% | $162.00m | |
| PBYI | Puma Biotechnology, Inc. | 1.22% | 87.50 | 21.1% | $145.68m | |
| KITE | Kite Pharma, Inc. | 7.09% | 100.66 | 16.1% | $139.56m | |
| EXAS | Exact Sciences Corporation | 2.31% | 35.51 | 26.3% | $130.55m |
Company Profile
Adaptimmune Therapeutics Plc is a clinical stage biopharmaceutical company, which focuses on novel cancer immunotherapy products based on T-cell receptor platform. Its TCR platform targets NY-ESO-1 cancer antigen. The company was founded in December 2014 and is headquartered in Oxford, the United Kingdom.,0FFS6L-E